Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01804465
Recruitment Status : Recruiting
First Posted : March 5, 2013
Last Update Posted : October 16, 2019
Sponsor:
Collaborators:
M.D. Anderson Cancer Center
Bristol-Myers Squibb
Dendreon
Information provided by (Responsible Party):
University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2020